The effects of modified ultrafiltration on pulmonary function and transfusion requirements in patients undergoing coronary artery bypass graft surgery;Efeitos da ultrafiltra̧ão modificada na fuņão pulmonar e necessidade de hemotransfusão em pacientes submetidos à revasculariza̧ão do miocárdio

Brazilian Journal of Cardiovascular Surgery

Volumn 25, Issue 1, 2010, Pages 59-65

  Torina, Anali Galluce ^a   Petrucci, Orlando ^a   de Oliveira, Pedro Paulo Martins ^a   de Oliveira Severino, Elaine Soraya Barbosa ^a   de Souza Vilarinho, Karlos Alexandre ^a   Lavagnoli, Carlos Fernando Ramos ^a   Blotta, Maria Heloisa ^a   Vieira, Reinaldo Wilson ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Coronary Artery Bypass; Hemorrhage; Thoracic Surgery; Ultrafiltration

Indexed keywords

ADULT; ADVERSE EFFECTS; ANALYSIS OF VARIANCE; BLOOD CLOTTING; BLOOD TRANSFUSION; BREATHING MECHANICS; CHI SQUARE DISTRIBUTION; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; FEMALE; HEMODYNAMICS; HEMOFILTRATION; HUMAN; MALE; PHYSIOLOGY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; STATISTICS AND NUMERICAL DATA;

ADULT; ANALYSIS OF VARIANCE; BLOOD COAGULATION; BLOOD TRANSFUSION; CHI-SQUARE DISTRIBUTION; CORONARY ARTERY BYPASS; FEMALE; HEMODYNAMICS; HEMOFILTRATION; HUMANS; MALE; RESPIRATORY MECHANICS;

EID: 77954236470     PISSN: 01027638     EISSN: 16789741     Source Type: Journal    
DOI: 10.1590/s0102-76382010000100014     Document Type: Article

References (21)

1. Liebold A, Keyl C, Birnbaum DE. The heart produces but the lungs consume proinflammatory cytokines following cardiopulmonary bypass. Eur J Cardiothorac Surg. 1999;15(3):340-5.
2. Chew MS, Brandslund I, Brix-Christensen V, Ravn HB, Hjortdal VE, Pedersen J, et al. Tissue injury and the inflammatory response to pediatric cardiac surgery with cardiopulmonary bypass: a descriptive study. Anesthesiology. 2001;94(5):745-53; discussion 5A.
3. Radaelli A, Loardi C, Cazzaniga M, Balestri G, DeCarlini C, Cerrito MG, et al. Inflammatory activation during coronary artery surgery and its dose-dependent modulation by statin/ ACE-inhibitor combination. Arterioscler Thromb Vasc Biol. 2007;27(12):2750-5.
4. Perrotta S, Lentini S. Ministernotomy approach for surgery of the aortic root and ascending aorta. Interact Cardiovasc Thorac Surg. 2009;9(5):849-58.
5. Allen M, Sundararajan S, Pathan N, Burmester M, Macrae D. Anti-inflammatory modalities: their current use in pediatric cardiac surgery in the United Kingdom and Ireland. Pediatr Crit Care Med. 2009;10(3):341-5.
6. McEvoy MD, Sabbagh MJ, Taylor AG, Zavadzkas JA, Koval CN, Stroud RE, et al. Aprotinin modifies left ventricular contractility and cytokine release after ischemia-reperfusion in a dose-dependent manner in a murine model. Anesth Analg. 2009;108(2):399-406.
7. Naik SK, Knight A, Elliott MJ. A successful modification of ultrafiltration for cardiopulmonary bypass in children. Perfusion. 1991;6(1):41-50.
8. Brancaccio G, Villa E, Girolami E, Michielon G, Feltri C, Mazzera E, et al. Inflammatory cytokines in pediatric cardiac surgery and variable effect of the hemofiltration process. Perfusion. 2005;20(5):263-8.
9. Boodhwani M, Williams K, Babaev A, Gill G, Saleem N, Rubens FD. Ultrafiltration reduces blood transfusions following cardiac surgery: a meta-analysis. Eur J Cardiothorac Surg. 2006;30(6):892-7.
10. MalufMA, Mangia C, Bertuccez J, Silva C, Catani R, Carvalho W, et al. Estudo comparativo da ultrafiltração convencional e associa ção de ultrafiltração convencional e modificada na correjao de cardiopatias congênitas com alto risco cirúrgico. Rev Bras Cir Cardiovasc. 1999;14(3):221-36.
11. Castro RP, Croti UA, Machado MN, Murillo HG, Rincon OYP, Policarpo SR, et al. Ultrafiltração convencional com modificação tecnica no tratamento cirúrgico dos defeitos cardiacos congênitos. Rev Bras Cir Cardiovasc. 2006;21(1):42-9.
12. Luciani GB, Menon T, Vecchi B, Auriemma S, Mazzucco A. Modified ultrafiltration reduces morbidity after adult cardiac operations: a prospective, randomized clinical trial. Circulation. 2001;104(12 Suppl 1):I253-9.
13. Ornato JP, Peberdy MA. Cardiopulmonary resuscitation. Totowa:Humana Press;2005.
14. Westaby S. Organ dysfunction after cardiopulmonary bypass. A systemic inflammatory reaction initiated by the extracorporeal circuit. Intensive Care Med. 1987;13(2):89-95.
15. Smetkin AA, Kirov MY, Kuzkov VV, Lenkin AI, Eremeev AV, Slastilin VY, et al. Single transpulmonary thermodilution and continuous monitoring of central venous oxygen saturation during off-pump coronary surgery. Acta Anaesthesiol Scand. 2009;53(4):505-14.
16. Mahmoud AB, Burhani MS, Hannef AA, Jamjoom AA, Al-Githmi IS, Baslaim GM. Effect of modified ultrafiltration on pulmonary function after cardiopulmonary bypass. Chest. 2005;128(5):3447-53.
17. Song LO, Yinglong LI, Jinping LI. Effects of zero-balanced ultrafiltration on procalcitonin and respiratory function after cardiopulmonary bypass. Perfusion. 2007;22(5):339-43.
18. Pérez-Vela JL, Ruiz-Alonso E, Guillén-Ramírez F, García-Maellas MT, Renes-Carreño E, Cerro-García M, et al. ICU outcomes in adult cardiac surgery patients in relation to ultrafiltration type. Perfusion. 2008;23(2):79-87.
19. Steffens TG, Kohmoto T, Edwards N, Wolman RL, Holt DW. Effects of modified ultrafiltration on coagulation as measured by the thromboelastograph. J Extra Corpor Technol. 2008;40(4):229-33.
20. Antunes N, Dragosavc D, Petrucci Junior O, Oliveira PPM, Kosour C, Blotta MHSL, et al. Ultrafiltraçáo para remover mediadores infamatórios durante circulaçáo extracorpórea na revascularizaçáo do miocárdio. Rev Bras Cir Cardiovasc. 2008;23(2):175-82.
21. Grunenfelder J, Zund G, SchoeberleinA, Maly FE, Schurr U, Guntli S, et al. Modified ultrafiltration lowers adhesion molecule and cytokine levels after cardiopulmonary bypass without clinical relevance in adults. Eur J Cardiothorac Surg. 2000;17(1):77-83.